breast cancer drug t-dm1 shows promise in trial
Published 12 years ago • 749 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
4:19
asco: new treatment (t-dm1) for her2-positive advanced breast cancer?
-
2:02
katherine trial: t-dm1 cuts her2-positve invasive breast cancer recurrence
-
1:21
katherine trial tests trastuzumab emtansine in breast cancer recurrence
-
3:36
t-dm1 shows promise in her-positive breast cancer
-
4:10
what’s new with her2-neu inhibition
-
6:13
cleopatra: success with dual her2 blockade in breast cancer
-
3:16
dual her2 blockade defers breast cancer in cleopatra
-
4:06
her2 patients may do fine with local therapies alone
-
9:17
san antonio roundtable, part 3: trastuzumab, bevacizumab, and angiogenesis inhibitors
-
3:18
adjuvant chemotherapy boosts survival in locoregional recurrent breast cancer
-
1:36
phase 3 trial investigates t-dm1 and pertuzumab in her2 breast cancer
-
3:00
genes may predict trastuzumab outcomes in breast cancer
-
0:56
t-dm1 as part of our standard of care with residual her 2 disease
-
4:52
emilia trial: t-dm1 in metastatic breast cancer
-
3:55
onc-chat: dr. martine piccart, 'absolutely no advantage' to 2 years of trastuzumab
-
2:48
new drugs show promise fighting aggressive breast cancer
-
5:40
t-dm1 breast cancer drug
-
5:54
the new t-dm1 breast cancer drug, an oncologist's reaction
-
3:58
promise breast cancer clinical trial